lipid-lowering response

COMPARATIVE ANALYSIS OF THE EFFECT OF HIGH-DOSE ATORVASTATIN ON BLOOD LIPID PROFILE AND HEPATIC CYTOLYSIS IN PATIENTS WITH MYOCARDIAL INFARCTION WITHOUT CONCOMITANT LIVER PATHOLOGY AND IN COMBINATION WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS